Back

Navigating cardiotoxicity risk in cancer therapy: the importance of the HFA-ICOS score

European Heart Journal

16 December 2024
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR DISEASE IN SPECIFIC POPULATIONS HEART FAILURE Chronic Heart Failure PREVENTIVE CARDIOLOGY Risk Factors and Prevention

Contributors

Lloyd E Butel-Simoes
Lloyd E Butel-Simoes

Author

Doan T M Ngo
Doan T M Ngo

Author

Aaron L Sverdlov
Aaron L Sverdlov

Author

University of Newcastle Newcastle , Australia

You may be interested in
thumbnail
Congress Presentation
Cardiovascular toxicity prediction in breast cancer patients: the HFA/ICOS risk tool in real-world practice
21 June 2025
thumbnail
Congress Presentation
Cardiac computed tomography and magnetic resonance for precision diagnosis and monitoring for better outcome
1 September 2025
thumbnail
Congress Session
Cardiotoxicity of cancer therapies
27 August 2023
thumbnail
Congress Session
New insights into cancer therapy-related cardiac dysfunction
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources